BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Rahmutulla B, Matsushita K, Nomura F. Alternative splicing of DNA damage response genes and gastrointestinal cancers. World J Gastroenterol 2014; 20(46): 17305-17313 [PMID: 25516641 DOI: 10.3748/wjg.v20.i46.17305]
URL: https://www.wjgnet.com/1007-9327/full/v20/i46/17305.htm
Number Citing Articles
1
Zeling Cai, Yi Wei, Shuai Chen, Yu Gong, Yue Fu, Xianghua Dai, Yan Zhou, Haojun Yang, Liming Tang, Hanyang Liu. Screening and identification of key biomarkers in alimentary tract cancers: A bioinformatic analysisCancer Biomarkers 2020; 29(2): 221 doi: 10.3233/CBM-201580
2
Kazuyuki Matsushita, Kouichi Kitamura, Bahityar Rahmutulla, Nobuko Tanaka, Takayuki Ishige, Mamoru Satoh, Tyuji Hoshino, Satoru Miyagi, Takeshi Mori, Sakae Itoga, Hideaki Shimada, Takeshi Tomonaga, Minoru Kito, Yaeko Nakajima-Takagi, Shuji Kubo, Chiaki Nakaseko, Masahiko Hatano, Takashi Miki, Masafumi Matsuo, Masaki Fukuyo, Atsushi Kaneda, Atsushi Iwama, Fumio Nomura. Haploinsufficiency of thec-myctranscriptional repressorFIR, as a dominant negative-alternative splicing model, promoted p53-dependent T-cell acute lymphoblastic leukemia progression by activating Notch1Oncotarget 2015; 6(7): 5102 doi: 10.18632/oncotarget.3244
3
Jun Jiang, Li Niu, Ming-Xia Zhang, Hao Wang, Jia-Qi Xie, Guo-Ping Sun, Fu Wang. A Novel Nomogram Combining Alternative Splicing Events and Clinical Factors for Prognosis Prediction in Head and Neck Squamous Cell CarcinomaJournal of Oncology 2022; 2022: 1 doi: 10.1155/2022/4552445
4
A. P. Kozlov. Expression of evolutionarily novel genes in tumorsInfectious Agents and Cancer 2016; 11(1) doi: 10.1186/s13027-016-0077-6
5
Xin Leng, Jianhu Liu, Anqi Jin, Hongfang Zheng, Jiulong Wu, Longfei Zhong, Qiaoxin Li, Dongfeng Li. Multi-omics Analyses Reveal Function of Apolipoprotein E in Alternative Splicing and Tumor Immune Microenvironment in Kidney Renal Clear Cell Carcinoma via Pan-cancer AnalysisCell Biochemistry and Biophysics 2024; 82(1): 1 doi: 10.1007/s12013-023-01211-7
6
Zodwa Dlamini, Rodney Hull, Sikhumbuzo Z Mbatha, Mohammed Alaouna, You-Lin Qiao, Herbert Yu, Aristotelis Chatziioannou. Prognostic Alternative Splicing Signatures in Esophageal CarcinomaCancer Management and Research 2021; : 4509 doi: 10.2147/CMAR.S305464
7
Yukiko Ogura, Tyuji Hoshino, Nobuko Tanaka, Guzhanuer Ailiken, Sohei Kobayashi, Kouichi Kitamura, Bahityar Rahmutulla, Masayuki Kano, Kentarou Murakami, Yasunori Akutsu, Fumio Nomura, Sakae Itoga, Hisahiro Matsubara, Kazuyuki Matsushita. Disturbed alternative splicing of FIR (PUF60) directed cyclin E overexpression in esophageal cancersOncotarget 2018; 9(33): 22929 doi: 10.18632/oncotarget.25149
8
M Kano, K Matsushita, B Rahmutulla, S Yamada, H Shimada, S Kubo, T Hiwasa, H Matsubara, F Nomura. Adenovirus-mediated FIR demonstrated TP53-independent cell-killing effect and enhanced antitumor activity of carbon-ion beamsGene Therapy 2016; 23(1): 50 doi: 10.1038/gt.2015.84
9
Sohei Kobayashi, Tyuji Hoshino, Takaki Hiwasa, Mamoru Satoh, Bahityar Rahmutulla, Sachio Tsuchida, Yuji Komukai, Tomoaki Tanaka, Hisahiro Matsubara, Hideaki Shimada, Fumio Nomura, Kazuyuki Matsushita. Anti-FIRs (PUF60) auto-antibodies are detected in the sera of early-stage colon cancer patientsOncotarget 2016; 7(50): 82493 doi: 10.18632/oncotarget.12696
10
Zhen Zong, Hui Li, Chenghao Yi, Houqun Ying, Zhengming Zhu, He Wang. Genome-Wide Profiling of Prognostic Alternative Splicing Signature in Colorectal CancerFrontiers in Oncology 2018; 8 doi: 10.3389/fonc.2018.00537
11
Yue Liu, Sally Do, Henry Huynh, Jing-Xin Li, Ying-Gao Liu, Zhi-Yan Du, Mo-Xian Chen. Importance of pre-mRNA splicing and its study tools in plantsAdvanced Biotechnology 2024; 2(1) doi: 10.1007/s44307-024-00009-9
12
Hao Li, Jingwei Liu, Shixuan Shen, Di Dai, Shitong Cheng, Xiaolong Dong, Liping Sun, Xiaolin Guo. Pan‐cancer analysis of alternative splicing regulator heterogeneous nuclear ribonucleoproteins (hnRNPs) family and their prognostic potentialJournal of Cellular and Molecular Medicine 2020; 24(19): 11111 doi: 10.1111/jcmm.15558